Streetbeat News

Products Services

AAPL

BABA

MSFT

NVDA

TSM

Taiwan Semiconductor Manufacturing Co (TSM) is reportedly a decade ahead of China's semiconductor industry, with plans to commercialize 2-nm chips by 2025. TSM remains a critical supplier to Nvidia and Apple, with strong demand from AI and smartphone sectors. Analysts have a positive outlook on TSM stock, with a 12-month price target of $234.0.

Portfolio Pulse from Anusuya Lahiri

October 01, 2024 | 11:43 am

BYDDF

BYDDY

BYD Co Ltd reported a 46% increase in September sales of new energy passenger vehicles, driven by a significant rise in plug-in hybrid sales. The company sold 417,603 vehicles, with plug-in hybrid sales up 86.2% and pure EV sales up 9%. BYD remains a key competitor to Tesla in the EV market.

Portfolio Pulse from Anan Ashraf

October 01, 2024 | 11:40 am

STLA

Stellantis (NYSE:STLA) has extended the production halt of its Fiat 500 electric car until November 1 due to low demand, highlighting challenges in the European EV market. Despite this, Stellantis plans to invest in a high-performance battery and introduce a hybrid version by 2026.

Portfolio Pulse from Benzinga Neuro

October 01, 2024 | 11:39 am

PSTV

Plus Therapeutics provided an update on its ReSPECT-GBM Phase 1/2 trial for Rhenium (186Re) Obisbemeda, showing safety and potential efficacy in treating recurrent glioblastoma. The trial has expanded to two new sites in the U.S.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 11:36 am

BHP

BHP forecasts a 70% increase in global copper demand by 2050, driven by economic growth, green energy, and digital developments. Despite recycling efforts, new mining projects are essential due to aging mines and declining ore grades.

Portfolio Pulse from Stjepan Kalinic

October 01, 2024 | 11:34 am

MGRX

Mangoceuticals has launched its new weight loss treatment, 'Slim,' which is an oral semaglutide available as a dissolvable tablet compounded with Vitamin B6. The product is now available on the company's website.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 11:34 am

NTLA

Intellia Therapeutics will present interim data from its Phase 1 study of NTLA-2001, a CRISPR-based therapy for ATTR amyloidosis, at the 2024 AHA Scientific Sessions. The presentation will cover safety, serum TTR reduction, and disease progression biomarkers.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 11:34 am

LI

NIO

TSLA

XPEV

Chinese EV companies Nio, XPeng, and Li Auto saw a premarket surge due to strong delivery numbers for September and Q3. Nio and XPeng are expanding into the mass market, while Li Auto continues to perform well. Tesla's upcoming delivery report is also anticipated.

Portfolio Pulse from Shanthi Rexaline

October 01, 2024 | 11:33 am

CTSO

CytoSorbents has submitted a De Novo marketing application to the FDA for its DrugSorb-ATR medical device. This device aims to reduce perioperative bleeding in patients on Ticagrelor undergoing coronary artery bypass graft surgery.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 11:27 am

LASE

Laser Photonics has received an order from Hemlock Semiconductor for its Handheld CleanTech CTIR-3040 Industrial Roughening Laser System, indicating potential growth in demand for its products.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 11:25 am